ColoGene
Clinical Genetic Test
Help
offered by
GTR Test Accession: Help GTR000596792.1
INHERITED DISEASECANCERSYNDROMIC DISEASE ... View more
Last updated in GTR: 2021-11-12
Last annual review date for the lab: 2024-04-03 LinkOut
At a Glance
Risk Assessment
Colorectal cancer, susceptibility to; Bannayan-Riley-Ruvalcaba syndrome; Breast and colorectal cancer, susceptibility to; ...
APC (5q22.2), ATM (11q22.3), BMPR1A (10q23.2), BRCA1 (17q21.31), CDH1 (16q22.1), ...
Molecular Genetics - Sequence analysis of the entire coding region: Next-Generation (NGS)/Massively parallel sequencing (MPS)
Individuals that meet NCCN criteria for Hereditary Gastrointestinal Cancer
Not provided
Not provided
Ordering Information
Offered by: Help
GeneID Lab - Advanced Molecular Diagnostics
View lab's website
Specimen Source: Help
Who can order: Help
  • Health Care Provider
  • Licensed Physician
  • Nurse Practitioner
Test Order Code: Help
CGN
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
Informed consent required: Help
Yes
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 41
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 19
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument
Sequence analysis of the entire coding region
Next-Generation (NGS)/Massively parallel sequencing (MPS)
Illumina MiniSeq
Clinical Information
Test purpose: Help
Risk Assessment
Target population: Help
Individuals that meet NCCN criteria for Hereditary Gastrointestinal Cancer
View citations (4)
  • ' ACOG Committee Opinion. Hereditary Cancer Syndromes and Risk Assessment. Committee on Genetics, Number 634, June 2015. Reaffirmed 2017.
  • ' ACOG Committee Opinion. Hereditary Cancer Syndromes and Risk Assessment. Committee on Genetics, Number 634, June 2015. Reaffirmed 2017. '
  • ' NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®). Genetic/Familial High-Risk Assesssment: Colorectal. Version 1.2018 - July 12, 2018. NCCN.org '
  • NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®). Genetic/Familial High-Risk Assesssment: Breast and Ovarian. Version 1.2019 - July 11, 2018. NCCN.org '
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
To establish analytical sensitivity and specificity, reference samples that contain both disease-associated and non-disease associated sequence variations were analyzed. Analytical sensitivity: The likelihood of the assay to detect a sequence variation when present within the analyzed genomic region (the test’s false negative rate) was established. All samples tested that have … View more
View citations (3)
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
No
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Not provided
Additional Information
Practice guidelines:
Consumer resources:

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.